Serum-Free Cell Culture Medium with Pterostilbene
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell therapy technologies face challenges in reducing costs, improving efficiency, and ensuring safety, particularly in the use of fetal bovine serum (FBS) for cell culture, which can lead to complications such as xenogenic infectious agent transmission and immunization, and in the production of serum-free and xeno-free culture media that are compatible with clinical-grade cell therapies.
Innovation Solution
A composition comprising pterostilbene, migration inhibitory factor antagonists, and bivalent cations is used as a medium or supplement for cell culture, expansion, preservation, and pretreatment, providing a serum-free and xeno-free environment that enhances cell culture, expansion, and preservation while reducing oxidative stress.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If fetal bovine serum (FBS) is used for cell culture, then cell proliferation is supported, but risk of xenogenic infectious agent transmission and immunization increases
Solution Approach 1:
The invention extracts and eliminates the harmful FBS component from the culture medium while retaining the essential growth support functions through alternative serum-free formulations, thereby removing the source of xenogenic contamination risk
Solution Approach 2:
The patent introduces intermediary substances such as platelet lysate or specific growth factors that mediate the cell culture process, replacing FBS as the nutrient source while maintaining cell proliferation capabilities without xenogenic risks
2Object-affected harmful factors
If serum-free and xeno-free culture media are used, then safety is improved, but cell culture efficiency and scalability are reduced
Solution Approach 1:
The invention optimizes parameters of the serum-free medium formulation, including concentrations of growth factors, amino acids, and other nutrients, to achieve both safety and high cell culture efficiency simultaneously
Solution Approach 2:
The patent develops composite culture media formulations combining multiple components (growth factors, cytokines, nutrients) that work synergistically to support robust cell proliferation in a serum-free, xeno-free environment
3Quantity of substance
If cells are cultured under stress conditions, then extracellular vesicle production increases, but cell viability and functionality decrease
Solution Approach 1:
The invention applies preliminary optimization of culture conditions and medium composition before vesicle induction, preparing cells in a healthy state that can withstand induction stress and maintain functionality while producing vesicles
Solution Approach 2:
The patent incorporates protective nutrients and growth factors in the culture medium that cushion cells against the harsh conditions of vesicle induction, preventing excessive stress damage while allowing vesicle production
Data Source
AI summary
The invention relates to a method and composition for the cultivation, expansion and production of extracellular vesicles, and the preservation and/or pre-treatment of cells, wherein said composition is a medium or media supplement or a solution comprising pterostilbene or the derivatives thereof, and/or a migration inhibitory factor antagonist and optionally a bivalent cation.